Glucagon-like peptide-1 analog liraglutide leads to multiple metabolic alterations in diet-induced obese mice

Liraglutide, a glucagon-like peptide-1 analog, has beneficial metabolic effects in patients with type 2 diabetes and obesity. Although the high efficacy of liraglutide as an anti-diabetic and anti-obesity drug is well known, liraglutide-induced metabolic alterations in diverse tissues remain largely...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Seokjae, Oh, Sungjoon, Kim, Eun-Kyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730228/
https://www.ncbi.nlm.nih.gov/pubmed/36356900
http://dx.doi.org/10.1016/j.jbc.2022.102682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730228/
https://www.ncbi.nlm.nih.gov/pubmed/36356900
http://dx.doi.org/10.1016/j.jbc.2022.102682

Ejemplares similares